Results from a large clinical trial funded by the National Institutes of Health show that an intervention for anxiety provided to pregnant women living in Pakistan significantly reduced the likelihood of the women developing moderate-to-severe anxiety, depression, or both six weeks after birth.
Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation – Pharmaceutical Technology
Bernie Sanders, an independent senator from Vermont, has released a report claiming that Novo Nordisk’s GLP-1 receptor drugs could bankrupt the US entire healthcare system.